Aloop Therapeutics

Aloop Therapeutics is a biotechnology company dedicated to the discovery and development of precision therapies for inflammatory and autoimmune diseases. The company utilizes a proprietary computational platform to identify pathogenic loops, which are self-sustaining circuits of cellular interactions that drive and maintain chronic inflammation. By targeting the specific nodes that anchor these loops, Aloop aims to develop treatments that are more effective and have fewer side effects than broad immunosuppressants. Their lead research program is currently focused on Ulcerative Colitis, with potential applications across a wide range of immune-mediated conditions. Founded by prominent scientists from the Technion and Hebrew University, Aloop is positioned at the intersection of systems immunology and drug discovery.